Pulling SEC filings + quote and writing the call…

Birchtech Corp.
Next earnings Aug 12, 2026 · consensus $-0.07 EPS, $4.39M rev
Negative-equity micro-cap whose core mercury-emissions market is being dismantled by MATS rollback; not investable on today's balance sheet.
Stockholders' equity -$1.71M · FY2025
Birchtech is a $17.6M-revenue specialty activated-carbon micro-cap whose fundamentals have gone nowhere for five years (revenue $13.0M→$21.6M→$17.6M→$17.4M→$17.6M) while the bottom line stays red. FY2025 net income was -$3.03M and operating margin -17.2%; the only profitable year (FY2023, +$5.67M) was driven by patent-litigation settlements, not operations. Book equity is now negative (-$1.71M) against a -$75.8M accumulated deficit, current assets ($5.00M) are less than half of current liabilities ($10.7M), and cash has fallen 35% to $2.25M. That is a balance sheet under stress, not one funding a turnaround.
The regulatory pillar under the core business is being actively pulled out. Management concedes the U.S. mercury-removal market 'has largely been driven by federal regulations' (MATS). The 10-K then discloses that on April 8, 2025 the President exempted 47 plant owners and 60+ power plants — 'which list includes a number of our customers' — from the updated MATS rule for July 2027–2029, and that in June 2025 the EPA proposed to repeal MATS outright. A demand base that only exists because regulation forces it is precisely the base now being deregulated, so the forward picture for the mercury franchise is worse than the flat revenue line suggests.
Is BCHT a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $13.0M | $21.6M | $17.6M | $17.4M | $17.6M |
| Gross profit | — | $7.02M | $5.45M | $7.10M | $7.40M |
| Operating income | — | $904K | -$8.97M | -$7.16M | -$3.03M |
| Net income | -$3.63M | -$1.58M | $5.67M | -$10.8M | -$3.03M |
| Diluted EPS | — | -$0.02 | $0.06 | -$0.57 | -$0.16 |
| Net margin | -27.9% | -7.3% | 32.2% | -62.1% | -17.2% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual proxy: director/auditor votes and comp; routine governance, no new financials
Q1-FY26: revenue flat, still loss-making, negative equity and thin $2.25M cash persist
Amends a prior 8-K to add required detail/exhibits; clerical, no new substance
Officer/director change (Item 5.02); leadership transition, no financial detail
Shareholder director-nomination notice (5.08) plus other-events update; housekeeping
FY25 net loss narrowed 72% to -$3.0M but equity negative; MATS rollback risks demand
Other-events disclosure (8.01), likely MATS/litigation update; no P&L impact stated
Entered a material definitive agreement (1.01) — potential license/settlement/contract
Second amendment to share registration — advancing an offering; dilution overhang
Sources: SEC EDGAR (CIK 0000728385, latest 10-Q filed 2026-05-13) · EODHD · Proprietary analysis · as of 7/3/2026, 4:58:05 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 12:58 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-02-27 | MacPherson Richard President and CEO | Buy | 313K @ $2.40 | $750K |
| 2025-12-12 | Kaye David M Director | Exercise | 250K @ $0.58 | $145K |
| 2025-12-12 | Kaye David M Director | Tax | 155K @ $0.93 | $145K |
| 2025-12-12 | MacPherson Richard President and CEO | Exercise | 500K @ $0.58 | $290K |
| 2025-12-12 | MacPherson Richard President and CEO | Tax | 310K @ $0.93 | $290K |
| 2025-12-11 | Pavlish John Senior VP/Chief Tech Officer | Exercise | 300K @ $0.58 | $174K |
| 2025-12-11 | Pavlish John Senior VP/Chief Tech Officer | Tax | 191K @ $0.91 | $174K |
| 2025-06-20 | Pavlish John Senior VP/Chief Tech Officer | Exercise | 500K @ $0.19 | $95.0K |
| 2025-06-20 | Pavlish John Senior VP/Chief Tech Officer | Tax | 181K @ $0.52 | $95.0K |
| 2025-06-20 | MacPherson Richard President and CEO | Exercise | 500K @ $0.19 | $95.0K |
| 2025-06-20 | MacPherson Richard President and CEO | Tax | 181K @ $0.52 | $95.0K |
| 2024-06-24 | Pavlish John Senior VP/Chief Tech Officer | Exercise | 1.00M @ $0.45 | $450K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median